Anastrozole: beside a new treatment under test
25 studies: a new drug, cell therapy or vaccine is what the study tests. Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNCT07568574Not applicableHow we knowReport a problem
- The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in HumansNot yet recruitingNCT07212712Not applicableHow we knowReport a problem
- Ribociclib for HR-positive HER2-negative Metastatic Breast CancerRecruitingNCT07164976Phase 1/2How we knowReport a problem
- A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 InhibitorsNot yet recruitingNCT07163481Phase 1How we knowReport a problem
- Brain Blood Flow Responses to Stress: Sex DifferencesCompletedNCT06253702Phase 4Results postedHow we knowReport a problem
- A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to ProgesteroneCompletedNCT03909152Phase 2Results postedHow we knowReport a problem
- This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast CancerCompletedNCT03099174Phase 1Results postedHow we knowReport a problem
- Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast CancerTerminatedNCT01776008Phase 2Results postedHow we knowReport a problem
- PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast CancerActive, not recruitingNCT01723774Phase 2Results postedHow we knowReport a problem
- Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast CancerCompletedNCT01597193Phase 1Results postedHow we knowReport a problem
- Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT00217399Phase 1/2Results postedHow we knowReport a problem
- A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast CancerActive, not recruitingNCT05257395Phase 3How we knowReport a problem
- SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.CompletedNCT04836520Phase 2How we knowReport a problem
- A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast CancerActive, not recruitingNCT04556773Phase 1How we knowReport a problem
- A Phase I/II Study of XZP-3287 in Metastasis Solid TumorsActive, not recruitingNCT04539496Phase 1/2How we knowReport a problem
- A Study of Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer.Status unknownNCT04236310Phase 2How we knowReport a problem
- Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.Active, not recruitingNCT03616587Phase 1How we knowReport a problem
- A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast CancerActive, not recruitingNCT02779751Phase 1How we knowReport a problem
- Open-label Phase 1b Study of ARQ 092 in Combination With AnastrozoleTerminatedNCT02476955Phase 1How we knowReport a problem
- Testosterone Regulation of the Natriuretic Peptide SystemWithdrawnNCT02269072Not applicableHow we knowReport a problem
- A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has SpreadActive, not recruitingNCT02057133Phase 1How we knowReport a problem
- A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)TerminatedNCT02000375Phase 2How we knowReport a problem
- Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt LoadingWithdrawnNCT01763541Early Phase 1How we knowReport a problem
- MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT01344031Phase 1How we knowReport a problem
- Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast CancerTerminatedNCT00303615Phase 2How we knowReport a problem